Report cover image

Next Generation Diabetes Therapy and Drug Delivery Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Nov 01, 2024
Length 146 Pages
SKU # PROD19315552

Description

Next Generation Diabetes Therapy and Drug Delivery Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global next generation diabetes therapy and drug delivery market is expected to grow at a CAGR of around 14.6% during 2025-2034. This report on global next generation diabetes therapy and drug delivery market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global next generation diabetes therapy and drug delivery market by segmenting the market based on product type, demographic, indication, end user, and region. Also, detailed profiles of companies operating in the next generation diabetes therapy and drug delivery market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rise in the Healthcare Expenditure
• Increase in the Disposable Income Among the Diabetic Patients

Market Challenges

• Lack of Awareness
• Less Variability in Products

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product Type

• Inhalable Insulin
• Oral Insulin
• Insulin Patches
• Continuous Glucose Monitoring Systems
• Artificial Pancreas

Market by Demographic

• Adult Population (>14 Years)
• Child Population (14 Years)

Market by Indication

• Type 1 Diabetes
• Type 2 Diabetes

Market by End User

• Clinics
• Intensive Care Units (ICUs)
• Home Healthcare

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

146 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Next Generation Diabetes Therapy and Drug Delivery Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Next Generation Diabetes Therapy and Drug Delivery Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type
5.1. Introduction
5.2. Inhalable Insulin
5.3. Oral Insulin
5.4. Insulin Patches
5.5. Continuous Glucose Monitoring Systems
5.6. Artificial Pancreas
6. Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic
6.1. Introduction
6.2. Adult Population (>14 Years)
6.3. Child Population (14 Years)
7. Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication
7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes
8. Global Next Generation Diabetes Therapy and Drug Delivery Market by End User
8.1. Introduction
8.2. Clinics
8.3. Intensive Care Units (ICUs)
8.4. Home Healthcare
9. Global Next Generation Diabetes Therapy and Drug Delivery Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. Abbott laboratories
13.2.2. Dexcom, Inc
13.2.3. Eli Lilly and Company
13.2.4. Glysens Incorporated
13.2.5. Johnson & Johnson
13.2.6. MannKind Corporation
13.2.7. Medtronic plc
13.2.8. Novo Nordisk A/S
13.2.9. Sanofi S.A.
13.2.10. Senseonics Holdings, Inc.
List of Figures
Figure 1: Global Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 2: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, 2024
Figure 3: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic, 2024
Figure 4: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication, 2024
Figure 5: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User, 2024
Figure 6: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region, 2024
Figure 7: Global Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 8: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (in %), 2024 & 2034
Figure 9: Global Inhalable Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 10: Global Inhalable Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 11: Global Oral Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 12: Global Oral Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 13: Global Insulin Patches Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 14: Global Insulin Patches Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 15: Global Continuous Glucose Monitoring Systems Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 16: Global Continuous Glucose Monitoring Systems Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 17: Global Artificial Pancreas Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 18: Global Artificial Pancreas Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 19: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic (in %), 2024 & 2034
Figure 20: Global Adult Population (>14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 21: Global Adult Population (>14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 22: Global Child Population (14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 23: Global Child Population (14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 24: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication (in %), 2024 & 2034
Figure 25: Global Type 1 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 26: Global Type 1 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 27: Global Type 2 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 28: Global Type 2 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 29: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User (in %), 2024 & 2034
Figure 30: Global Clinics Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 31: Global Clinics Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 32: Global Intensive Care Units (ICUs) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 33: Global Intensive Care Units (ICUs) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 34: Global Home Healthcare Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 35: Global Home Healthcare Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 36: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region (in %), 2024 & 2034
Figure 37: Europe Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 38: Europe Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 39: Europe Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2024 & 2034
Figure 40: Germany Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 41: United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 42: France Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 43: Italy Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 44: Spain Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 45: Russia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 46: Netherlands Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 47: North America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 48: North America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 49: North America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2024 & 2034
Figure 50: United States Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 51: Canada Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 52: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 53: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 54: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2024 & 2034
Figure 55: China Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 56: Japan Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 57: India Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 58: South Korea Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 59: Australia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 60: Indonesia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 61: Latin America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 62: Latin America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 63: Latin America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2024 & 2034
Figure 64: Mexico Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 65: Brazil Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 66: Argentina Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 67: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2024
Figure 68: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2025-2034
Figure 69: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2024 & 2034
Figure 70: Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 71: Turkey Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 72: Iran Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 73: UAE Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2020-2034
Figure 74: Market Value Chain
List of Tables
Table 1: Global Next Generation Diabetes Therapy and Drug Delivery Market Portraiture
Table 2: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (in US$ Million), 2024 & 2034
Table 3: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic (in US$ Million), 2024 & 2034
Table 4: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication (in US$ Million), 2024 & 2034
Table 5: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User (in US$ Million), 2024 & 2034
Table 6: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us